Cargando…

Limits of [(18)F]-FLT PET as a Biomarker of Proliferation in Oncology

BACKGROUND: Non-invasive imaging biomarkers of cellular proliferation hold great promise for quantifying response to personalized medicine in oncology. An emerging approach to assess tumor proliferation utilizes the positron emission tomography (PET) tracer 3’-deoxy-3’[(18)F]-fluorothymidine, [(18)F...

Descripción completa

Detalles Bibliográficos
Autores principales:	McKinley, Eliot T., Ayers, Gregory D., Smith, R. Adam, Saleh, Samir A., Zhao, Ping, Washington, Mary Kay, Coffey, Robert J., Manning, H. Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598948/ https://www.ncbi.nlm.nih.gov/pubmed/23554961 http://dx.doi.org/10.1371/journal.pone.0058938

Ejemplares similares

3′-Deoxy-3′-[(18)F]-Fluorothymidine PET Imaging Reflects PI3K-mTOR-Mediated Pro-Survival Response to Targeted Therapy in Colorectal Cancer
por: McKinley, Eliot T., et al.
Publicado: (2014)

Extramedullary haematopoiesis imaging with (18)F-FLT PET
por: Agool, Ali, et al.
Publicado: (2010)

PET Cell Tracking Using (18)F-FLT is Not Limited by Local Reuptake of Free Radiotracer
por: MacAskill, Mark G., et al.
Publicado: (2017)

Dual time point [(18)F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
por: Lovinfosse, Pierre, et al.
Publicado: (2019)

(18)F-FLT PET/CT in Patients with Gastric Carcinoma
por: Małkowski, Bogdan, et al.
Publicado: (2013)

Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer
por: Christensen, Tine N., et al.
Publicado: (2021)

Cell proliferation detected using [(18)F]FLT PET/CT as an early marker of abdominal aortic aneurysm
por: Gandhi, Richa, et al.
Publicado: (2019)

A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma
por: Costantini, Danny L., et al.
Publicado: (2016)

Noninvasive quantification of (18)F-FLT human brain PET for the assessment of tumour proliferation in patients with high-grade glioma
por: Backes, Heiko, et al.
Publicado: (2009)

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined (18)F-FDG and (18)F-FLT PET/CT imaging
por: Sachpekidis, C., et al.
Publicado: (2018)

An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
por: Collet, Solène, et al.
Publicado: (2021)

(18)F-FLT PET/CT imaging in a Wister rabbit inflammation model
por: TAN, YEYING, et al.
Publicado: (2014)

(18)F-FLT PET/MRI for bone marrow failure syndrome-initial experience
por: Tsujikawa, Tetsuya, et al.
Publicado: (2019)

Depicting Changes in Tumor Biology in Response to Cetuximab Monotherapy or Combination Therapy by Apoptosis and Proliferation Imaging Using (18)F-ICMT-11 and (18)F-FLT PET
por: Heinzmann, Kathrin, et al.
Publicado: (2018)

Prospective comparison of early interim (18)F-FDG-PET with (18)F-FLT-PET for predicting treatment response and survival in metastatic breast cancer
por: Su, Tzu-Pei, et al.
Publicado: (2021)

Differences between [(18)F]FLT and [(18)F]FDG Uptake in PET/CT Imaging in CC Depend on Vaginal Bacteriology
por: Burchardt, Ewa, et al.
Publicado: (2021)

Effects of capecitabine treatment on the uptake of thymidine analogs using exploratory PET imaging agents: (18)F-FAU, (18)F-FMAU, and (18)F-FLT
por: McHugh, Christopher I., et al.
Publicado: (2016)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

(18)F-FLT Positron Emission Tomography (PET) is a Pharmacodynamic Marker for EWS-FLI1 Activity and Ewing Sarcoma
por: Osgood, Christy L., et al.
Publicado: (2016)

Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[(18)F]-Fluoro-L-Thymidine ([(18)F]FLT) Positron Emission Tomography (PET)
por: Ullrich, Roland T., et al.
Publicado: (2008)

[18F]FLT and [18F]FDG PET for Non-invasive Treatment Monitoring of the Nicotinamide Phosphoribosyltransferase Inhibitor APO866 in Human Xenografts
por: Munk Jensen, Mette, et al.
Publicado: (2013)

[(18)F]FDG and [(18)F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer
por: Raccagni, Isabella, et al.
Publicado: (2018)

Evaluation of the Performance of 18F-Fluorothymidine Positron Emission Tomography/Computed Tomography (18F-FLT-PET/CT) in Metastatic Brain Lesions
por: Nikaki, Alexandra, et al.
Publicado: (2019)

Insight into the dynamics, localization and magnitude of antigen-specific immune responses by [(18)F]FLT PET imaging
por: Aarntzen, Erik H.J.G., et al.
Publicado: (2012)

Early Assessment of the Efficacy of Temozolomide Chemotherapy in Experimental Glioblastoma Using [(18)F]FLT-PET Imaging
por: Viel, Thomas, et al.
Publicado: (2013)

Early Detection of Response to Experimental Chemotherapeutic Top216 with [(18)F]FLT and [(18)F]FDG PET in Human Ovary Cancer Xenografts in Mice
por: Munk Jensen, Mette, et al.
Publicado: (2010)

Early Response Assessment to Targeted Therapy Using 3′-deoxy-3′[(18)F]-Fluorothymidine ((18)F-FLT) PET/CT in Lung Cancer
por: Kairemo, Kalevi, et al.
Publicado: (2020)

Non-invasive Early Response Monitoring of Nanoparticle-assisted Photothermal Cancer Therapy Using (18)F-FDG, (18)F-FLT, and (18)F-FET PET/CT Imaging
por: Jørgensen, Jesper Tranekjær, et al.
Publicado: (2018)

Early assessment of response to induction therapy in acute myeloid leukemia using (18)F-FLT PET/CT
por: Han, Eun Ji, et al.
Publicado: (2017)

Quantitative Assessment of Bone Marrow Activity Using (18)F-FLT PET in Aplastic Anemia and Myelodysplastic Syndromes
por: Tasaki, Toshiki, et al.
Publicado: (2022)

Hematopoiesis in the spleen after engraftment in unrelated cord blood transplantation evaluated by (18)F-FLT PET imaging
por: Araie, Hiroaki, et al.
Publicado: (2023)

Toxicology evaluation of radiotracer doses of 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses
por: Turcotte, Eric, et al.
Publicado: (2007)

Correction: Christensen et al. Impact of [(18)F]FDG-PET and [(18)F]FLT-PET-Parameters in Patients with Suspected Relapse of Irradiated Lung Cancer. Diagnostics 2021, 11, 279
por: Christensen, Tine N., et al.
Publicado: (2022)

(18)F-FDG and (18)F-FLT-PET Imaging for Monitoring Everolimus Effect on Tumor-Growth in Neuroendocrine Tumors: Studies in Human Tumor Xenografts in Mice
por: Bardram Johnbeck, Camilla, et al.
Publicado: (2014)

Intratumoral (18)F-FLT infusion in metabolic targeted radiotherapy
por: Tippayamontri, Thititip, et al.
Publicado: (2019)

(18)F-fluorodeoxyglucose (FDG) PET or (18)F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
por: Romine, Perrin E., et al.
Publicado: (2021)

Evaluation of (18)F-fluorothymidine positron emission tomography ([(18)F]FLT-PET/CT) methodology in assessing early response to chemotherapy in patients with gastro-oesophageal cancer
por: Sharma, R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nkqq3ki0rknucbjhbeq264a90j